优降脂对老年高脂血症影响的临床研究

为了验证优降脂对老年高脂血症的影响,我们于1991年10～12月对此药进行了61例临床观察,现将结果报告于下。资料与方法一、临床资料本组共61例,均为原发性高脂血症患者,病例选择参照中华人民共和国卫生部试行的"药物临床研究指导原则"中调整血脂药物研究制定的标准。其中男性28例,女性33例。老年前期(45～59岁)25例,老年期(≥60岁)36例,平均年龄60.36±7.19岁(x±S),单纯甘油三酯(TG)增高者(≥250mg/dl)3例,单纯胆固醇(TC)增高者(≥150mg/dl)39例,TC和TG均高者18例,高密度脂蛋白低者(男性≤40mg/dl,女性≤45mg/dl)1例。全部观察对象按2:1比例随机分为治疗组和对照组,其中治

Clinical Study of Effect of Youjiangzhi Capsule on Senile Hyperlipidemia

61 aged with hyperlipidemia were randomly divided into treatment and condol group accordingto the ratio of 2:1, which were treated with Youjiangzhi capsule and Mai-an Powder respectively.After 8 weeks of administration, all of the four indexes of blood lipid (TC, TG, HDL-C, TC-HDL-C/HDL-C) were significantly improved in both groups, but the effective rate of TC-HDL-C/HDL-Cwas much better in treatment group than that in control. The result showed that there was a goodeffect of Youjiangzhi Capsule on the senile hyperlipidemia.